Coronavirus Update: After Trump Pressure, US FDA Issues Emergency Use Authorization For Blood Plasma Therapy
Agency Reverses Decision
• By Scrip Team
The Emergency Use Authorization will expand access to convalescent blood plasma - but a lack of a placebo-controlled study remains a cause for concern.
Keep up with the top pharma business news of the week. On the go.
